Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-025445

SVP & Chief Accounting Officer sold 13,881 shares at $101.46 ($1,408,366)

  • SVP & Chief Accounting Officer acquired 13,881 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2018-04-16 Option exercise +13,881 $10.69 $148,388 82,738 D: show line 1 in the form
Thomsen Jillian B. SVP & Chief Accounting Officer 2018-04-16 Sale −13,881 $101.46 $1,408,366 68,857 D: show line 2 in the form
Open-market sales · 13,881 sh · avg $101.46 · $1,408,366

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2018-04-16 Option exercise · Stock Option −13,881 16,119 D: show line 3 in the form
Loading xslF345X03/doc4.xml…